Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atrayee BasuMallick

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
International Journal of Surgical Pathology|March 20, 2024
Synchronous Low-Grade Central Osteosarcoma and Ewing Sarcoma: A Rare Case ReportDaniel Christensen, Jeffrey A Belair, Atrayee BasuMallick, et al.
Journal for Immunotherapy of Cancer|January 22, 2026
Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancerDung T Le, Gunnar Folprecht, Anna M Varghese, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
International Journal of Surgical Pathology|March 20, 2024
Synchronous Low-Grade Central Osteosarcoma and Ewing Sarcoma: A Rare Case ReportDaniel Christensen, Jeffrey A Belair, Atrayee BasuMallick, et al.
Journal for Immunotherapy of Cancer|January 22, 2026
Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancerDung T Le, Gunnar Folprecht, Anna M Varghese, et al.
Pageof 1